AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10224212
Drug: Intraoral sucrose
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoral sucrose (48% solution) before feeding
Trial: 10224212
Drug: Intraoral sucrose
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoral sucrose (48% solution) after feeding
Trial: 10224212
Drug: Intraoral sucrose
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoral sucrose (48% solution)
Trial: 1877037
Drug: Budesonide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (200 micrograms twice daily) and terbutaline (500 micrograms four times daily)
Trial: 7088766
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg ergotamine by injection (6 i.v. and 11 i.m.)
Trial: 7088766
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg ergotamine by mouth
Trial: 7088766
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg ergotamine by suppository
Trial: 7088766
Drug: Plasma ergotamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma ergotamine levels exceeding 1.8 ng/ml
Trial: 31172717
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS) via transnasal nebulization
Trial: 31172717
Drug: Budesonide nasal
RxNorm normalized name: budesonide nasal
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide nasal spray (BNS)
Trial: 24282036
Drug: Two-step 50
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Two-step 50 g Glucose Challenge Test (GCT)
Trial: 24282036
Drug: 75 g
RxNorm normalized name: Zosyn 3.375 GM Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 g Glucose Tolerance Test (GTT)
Trial: 18976320
Drug: Carbamazepine (subgroup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine (subgroup of AED monotherapy)
Trial: 3071266
Drug: Clindamycin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin (3 x 600 mg in 100 ml 0.9% saline)
Trial: 3071266
Drug: Metronidazole (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (3 x 500 mg in 100 ml 0.9% saline)
Trial: 3071266
Drug: Placebo (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3 x 100 ml of 0.9% saline)
Trial: 23015618
Drug: Computer-controlled infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Computer-controlled infusion of phenylephrine (100 µg ml(‐1))
Trial: 23015618
Drug: Manual-controlled infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual-controlled infusion of phenylephrine
Trial: 23015618
Drug: Computer-controlled infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Computer-controlled infusion of phenylephrine
Trial: 12833013
Drug: Clobetasol propionate
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate 0.05% foam plus vehicle spray
Trial: 12833013
Drug: Clobetasol propionate
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate 0.05% foam plus 0.25% zinc pyrithione spray
Trial: 10827212
Drug: 20 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g/d FOS
Trial: 1520648
Drug: Atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50 mg bid)
Trial: 1520648
Drug: Nifedipine (20-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20-40 mg bid)
Trial: 30773564
Drug: Interscalene brachial
RxNorm normalized name: Brachiara mutica pollen
DrugBank: Urochloa mutica pollen (DB10716)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interscalene brachial plexus block (group I) with 0.2% ropivacaine 10 mL
Trial: 30773564
Drug: C5‐6 nerve
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C5‐6 nerve root block (group C) with 0.2% ropivacaine 10 mL
Trial: 19372331
Drug: Propofol 1
RxNorm normalized name: propofol 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1 mg/kg followed by an infusion of 2.5 mg x kg(‐1) x h(‐1) for 59 min
Trial: 19372331
Drug: Midazolam (C(blood):
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (C(blood): 225 ng/mL)
Trial: 16894336
Drug: Low-dose EPT
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose EPT (1 mg 17beta-estradiol + 0.5 mg norethisterone acetate)
Trial: 16894336
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (T and low-dose EPT)
Trial: 15136349
Drug: Rectal-contrast CT
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal-contrast CT scan
Trial: 11280073
Drug: Polonga TAb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polonga TAb (1 g)
Trial: 11280073
Drug: Haffkine antivenom
RxNorm normalized name: ANTIVENIN,CROTALIDAE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haffkine antivenom (10 g)
Trial: 29617982
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg single oral dose of gepotidacin
Trial: 29617982
Drug: 3000 mg
RxNorm normalized name: talc 3000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3000 mg single oral dose of gepotidacin
Trial: 29617982
Drug: Combined dose
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined dose groups (1500 mg and 3000 mg)
Trial: 26020712
Drug: Vortioxetine 15-20
RxNorm normalized name: vortioxetine 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vortioxetine 15-20 mg
Trial: 12764691
Drug: Thiopental 5‐7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental 5‐7 mg/kg IV
Trial: 12764691
Drug: Etomidate 0.2‐0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.2‐0.3 mg/kg IV
Trial: 1589135
Drug: L-sulpiride (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-sulpiride (75 mg die per os)
Trial: 1589135
Drug: Metoclopramide (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide (30 mg die per os)
Trial: 6112039
Drug: Pirbuterol (beta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirbuterol (beta agonist with vasodilator and positive inotropic properties)
Trial: 6112039
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of pirbuterol
Trial: 6112039
Drug: Incremental doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incremental doses of pirbuterol
Trial: 27842315
Drug: Indomethacin (0.2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (0.2, 0.1, and 0.1 mg/kg i.v. every 24 h for 3 doses)
Trial: 27842315
Drug: Ibuprofen lysine
RxNorm normalized name: Ibuprofen Lysine
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen lysine (10, 5, and 5 mg/kg i.v. every 24 h for 3 doses)
Trial: 21286719
Drug: Cisplatin-based chemotherapy
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin-based chemotherapy concurrent with radiotherapy
Trial: 19038534
Drug: Aripiprazole 30
RxNorm normalized name: aripiprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 30 mg/day (immediate initiation with simultaneous discontinuation of olanzapine/risperidone)
Trial: 19038534
Drug: Aripiprazole 30
RxNorm normalized name: aripiprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 30 mg/day (immediate initiation while tapering off olanzapine/risperidone over 14 days)
Trial: 19038534
Drug: Aripiprazole 30
RxNorm normalized name: aripiprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 30 mg/day (titrating upwards while tapering off olanzapine/risperidone over 14 days)
Trial: 19038534
Drug: Aripiprazole 30
RxNorm normalized name: aripiprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole 30 mg/day (all groups)
Trial: 17061999
Drug: FTY720 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTY720 2.5 mg plus full-dose cyclosporine (FDC)
Trial: 17061999
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) plus full-dose cyclosporine (FDC)
Trial: 17198261
Drug: FTY720 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTY720 5 mg plus reduced-dose cyclosporine (RDC)
Trial: 12697283
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (CoQ10) supplementation (360 mg daily for 4 weeks)
Trial: 10521100
Drug: 3.75 mg
RxNorm normalized name: zopiclone 3.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 mg i.m. dose of triptorelin
Trial: 7595707
Drug: Tamoxifen (TAM;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (TAM; 20 mg/d)
Trial: 7595707
Drug: Toremifene (TOR;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toremifene (TOR; 60 mg/d)
Trial: 7595707
Drug: Toremifene (TOR;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toremifene (TOR; 200 mg/d)
Trial: 6161320
Drug: (‐)Deprenyl 10
RxNorm normalized name: (11C)L-deprenyl-D2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (‐)Deprenyl 10 mg daily for 4 weeks
Trial: 28202404
Drug: Single-dose rhC1-INH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose rhC1-INH 50 U/kg
Trial: 28202404
Drug: Single-dose rhC1-INH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose rhC1-INH 2100 U
Trial: 28202404
Drug: Additional doses
RxNorm normalized name: chromous chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional doses after initial rhC1-INH 2100 U dose (total dose, 4200-6300 U)
Trial: 26272170
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) applied on the day of separation
Trial: 21525161
Drug: 17β‐estradiol 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17β‐estradiol 0.05 mg/d
Trial: 21525161
Drug: zolpidem 10
RxNorm normalized name: zolpidem 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: zolpidem 10 mg/d
Trial: 17178983
Drug: Imiquimod in
RxNorm normalized name: Product containing imiquimod in cutaneous dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod in combination with meglumine antimoniate
Trial: 1727882
Drug: 1% silver
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% silver sulfadiazine cream applied twice daily to the urethral meatus
Trial: 6395321
Drug: Naproxen (NAP)
RxNorm normalized name: Naproxen
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen (NAP) 10 mg/kg/day
Trial: 6395321
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 75 mg/kg/day
Trial: 26947697
Drug: Propylbetaine‐polihexanide (PP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propylbetaine‐polihexanide (PP) solution (Prontosan)
Trial: 26947697
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (NS) solution
Trial: 11696205
Drug: Indomethacin (0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (0.7 mg/kg, t.i.d.)
Trial: 3241272
Drug: Aerobic (lactate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerobic (lactate threshold) exercise therapy for 10 weeks
Trial: 29189426
Drug: Lifestyle physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifestyle physical activity (moderate physical activity during routine daily activities)
Trial: 26265447
Drug: CryoSeal® (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CryoSeal® (5 ml per ITA bed)
Trial: 20941948
Drug: Chitosan-containing spray
RxNorm normalized name: Chitosan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chitosan-containing spray (1% concentration, low molecular chitosan, degree of deacetylation 87%)
Trial: 20941948
Drug: Chitosan-free control
RxNorm normalized name: Chitosan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chitosan-free control (vehicle only) spray
Trial: 18371465
Drug: MC-1 (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MC-1 (250 mg/d)
Trial: 14750576
Drug: Prednisolone treatment
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone treatment starting at 40 mg/day, tapered by 5 mg every 2 weeks for 16 weeks
Trial: 8766365
Drug: Pharmacotherapy during
RxNorm normalized name: Pro-C-Dure 6 Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy during psychotherapy stages
Trial: 8766365
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of pharmacotherapy and psychotherapy
Trial: 2012511
Drug: Prednisone 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 0.3 mg/kg
Trial: 2012511
Drug: Prednisone 0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 0.75 mg/kg
Trial: 6802095
Drug: Phosphate therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphate therapy
Trial: 12351551
Drug: G1/G2 sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G1/G2 sequential culture system for 5 days
Trial: 7669385
Drug: DTP vaccine
RxNorm normalized name: DTP Vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTP vaccine (batch 1)
Trial: 7669385
Drug: DTP vaccine
RxNorm normalized name: DTP Vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTP vaccine (batches 2 and 3)
Trial: 7362083
Drug: Fenoterol hydrobromide
RxNorm normalized name: Fenoterol hydrobromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol hydrobromide (Berotec) 0.1% solution, 60 micrograms per nostril every six hours
Trial: 7362083
Drug: Fenoterol hydrobromide
RxNorm normalized name: Fenoterol hydrobromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol hydrobromide (Berotec) 0.1% solution, doubled dosage
Trial: 6341684
Drug: Chlorthalidone, 100
RxNorm normalized name: Chlorthalidone, 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone, 100 mg/day for 6 weeks
Trial: 29912604
Drug: DHA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA supplementation (2000 mg/day)
Trial: 27741174
Drug: Enoxaparin plus
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin plus Aspirin (4,000 IU enoxaparin + 100 mg aspirin)
Trial: 27741174
Drug: Aspirin alone
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin alone (100 mg aspirin)
Trial: 25474427
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg indomethacin
Trial: 25474427
Drug: Antiplatelet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet therapy (ASA)
Trial: 25474427
Drug: No antiplatelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antiplatelet therapy (non-ASA)
Trial: 18581020
Drug: Fast-track group
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast-track group (continuous infusion of fentanyl and propofol, atracurium one hour later)
Trial: 18581020
Drug: Conventional extubation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional extubation group (bolus doses of fentanyl and pancuronium)
Trial: 15858063
Drug: Yohimbine (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine (selective alpha2‐adrenoceptor antagonist)
Trial: 7018051
Drug: Cinoxacin 250
RxNorm normalized name: cinoxacin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinoxacin 250 mg four times a day (QID)
Trial: 7018051
Drug: Cinoxacin 500
RxNorm normalized name: cinoxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinoxacin 500 mg twice a day (BID)
Trial: 8238122
Drug: 100 IU
RxNorm normalized name: Vitamin E 100 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 IU of oxytocin in 20 ml of normal saline solution
Trial: 8238122
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml of normal saline solution (placebo)
Trial: 26609282
Drug: Ashwagandha (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ashwagandha (300 mg twice daily)
Trial: 15334426
Drug: Lumiracoxib 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumiracoxib 100 mg twice daily
Trial: 16888080
Drug: SHiDo chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SHiDo chemotherapy
Trial: 12741348
Drug: Menotropin treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menotropin treatment for three months (Group A)
Trial: 12741348
Drug: Menotropin treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menotropin treatment starting three months after surgery (Group B)
Trial: 1411848
Drug: Single-day split
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-day split dose of 1.6 g of metronidazole
Trial: 1411848
Drug: Single 2-g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 2-g dose of tinidazole
Trial: 29106665
Drug: Nivolumab 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab 3 mg/kg every 2 weeks (NIVO3)
Trial: 29106665
Drug: Nivolumab 1
RxNorm normalized name: nivolumab 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab 1 mg/kg + ipilimumab 3 mg/kg every 3 weeks for 4 doses (NIVO1+IPI3)
Trial: 29106665
Drug: Nivolumab 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab 3 mg/kg + ipilimumab 1 mg/kg every 3 weeks for 4 doses (NIVO3+IPI1)
Trial: 18263997
Drug: Breast health
RxNorm normalized name: Ascorbic Acid/Bioflavonoid/Broccoli/Curcumin/Flaxseed/Genistein/Selenium 100 MG-50 MG-85 MG-300 MG-200 MG-10 MG-0.1 MG Oral Tablet [PROHERBS BREAST HEALTH]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast health messages administered by salon stylists
Trial: 16080872
Drug: Triptorelin (3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triptorelin (3.75 mg injected intramuscularly every 28 days for 3 months)
Trial: 16080872
Drug: Leuprorelin (3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprorelin (3.75 mg injected subcutaneously every 28 days for 3 months)
Trial: 12435290
Drug: CVAP +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVAP + docetaxel (100 mg/m2)
Trial: 7577853
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg danazol daily (n = 17)
Trial: 7577853
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg gestrinone twice weekly (n = 19)
Trial: 7682931
Drug: Scopolamine (0.25‐0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine (0.25‐0.75 mg, intramuscular)
Trial: 7682931
Drug: Scopolamine (0.50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine (0.50 and 0.75 mg, intramuscular)
Trial: 29996980
Drug: PRPFM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRPFM treatment group
Trial: 26086792
Drug: Prolonged-release melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged-release melatonin 2 mg daily
Trial: 24296517
Drug: High-dose calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose calcium lactate (300 mg · kg(‐1) body mass)
Trial: 24296517
Drug: Low-dose calcium
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose calcium lactate (150 mg · kg(‐1) body mass)
Trial: 22728514
Drug: Infusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion of intestinal microbiota from lean donors
Trial: 22728514
Drug: Autologous microbiota
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous microbiota infusion
Trial: 20508469
Drug: Thermogenic drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thermogenic drink (TD) - 336 mL daily
Trial: 20508469
Drug: Placebo (PLA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PLA) - 336 mL daily
Trial: 12627313
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C supplementation (3 x 500 mg tablets daily for 7 days prior to race and 150 mg/l in carbohydrate beverages during race)
Trial: 12627313
Drug: Placebo (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3 tablets daily for 7 days prior to race and no vitamin C in carbohydrate beverages during race)
Trial: 8291920
Drug: Granisetron plus
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron plus MPL (10 mg/kg)
Trial: 5787671
Drug: LB46, 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LB46, 0.5 mg by oral administration